ABSTRACT
Objective Thisstudyaimstoexploretheeffectofmeasurement-basedcareusingPatientHealthQuestionnaire DepressionScale(PHQ-9)onpatientswithonsetdepression.Methods Atotalof120patientswithonsetdepressionwere randomly assigned to the test group and control group.The test group was treated with measurement-based care using PHQ-9 and the control group maintains normal treatment.We assessed the HAMD1 7 score and social function of all patients on acute phase (after two month treatment),middle phase (after six month treatment)and long phase (after one year treatment).Results ThemeanHAMD17scoreofpatientsinthetestgroupwaslowerthanthecontrolgroupat6monthand 1 2month(P<0.01 ),and the difference of the reduced score at 1 2month was significant (P<0.01 ).The patients has better social function score and lower recurrence rate in the test group than that of the control group (P <0.05 ). Conclusion Theonsetdepressivepatientwhotreatedwithmeasurement-basedcareusingPHQ-9showsbettereffect and social function compared with those with normal outpatient treatment.
ABSTRACT
<p><b>OBJECTIVE</b>To observe the effect of Zaoren Anshen capsules in treating senile insomnia and changes in its hemorheology.</p><p><b>METHOD</b>A total of 120 patients with senile insomnia were randomly divided into the Zaoren Anshen capsules group (five capsules, n = 60) and the Alprazolam group (0.8 mg, n = 60) for treatment and control observation. Pittsburgh sleep quality index (PSQI) was used for evaluating clinical efficacy in the first and fourth week before and after treatment.</p><p><b>RESULT</b>The Zaoren Anshen capsules group had lower higher scores in PSQI (5.91 +/- 1.37) than that before treatment (13.49 +/- 3.87), with great statistical significant in difference (P < 0.01). The alprazolam group had lower higher scores in PSQI than that before treatment, with great statistical significant in difference (P < 0.01). apart from higher PSQI scores in the Zaoren Anshen capsules group than that of the Alprazolam group after treatment for one week (P < 0.05), the comparison between the Zaoren Anshen capsules group and the alprazolam group before and after treatment for four weeks showed no statistical significance. As for hemorheological parameters, the difference in the whole blood viscosity (including high-shear, middle-shear and low-shear) of patients in the Zaoren Anshen capsules showed great statistical significance before and after treatment (P < 0.01), and so did the plasma viscosity (P < 0.05). Zaoren Anshen capsules showed less adverse reactions than alprazolam.</p><p><b>CONCLUSION</b>Zaoren Anshen capsules have similar effect in treating senile insomnia with alprazolam, with less adverse reactions. They are so suitable for patients with senile insomnia that they can improve hemorheological indicators of patients with senile insomnia and have good effect in promoting circulation and removing stasis.</p>
Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Alprazolam , Blood Viscosity , Capsules , Drugs, Chinese Herbal , Hemorheology , Hypnotics and Sedatives , Sleep Initiation and Maintenance Disorders , Drug Therapy , Surveys and Questionnaires , Treatment OutcomeABSTRACT
@#ObjectiveTo explore the cognitive psychological characteristics of the insomniac and the effect of cognitive therapy.Methods93 insomniac in-patients were divided randomly into the trial group (n=47) and control group (n=46). The trial group was treated by cognitive therapy plus medicine. The control group was only treated with medicines. The treatment lasted for 8 weeks. Before and after treatment, patients of all two groups were examined by Beliefs and Attitudes about Sleep Scale (DBAS). 45 healthy individuals were also examined at the same time. The therapeutic effect was evaluated with Pittsburgh Sleep Quality Index (PSQI).ResultsBefore treatment, DBAS scores of insomniacs were significantly different from the healthy (P<0.001). After treatment, scores of DBAS and PSQI of the trial group were significantly different from that of the control group ( P<0.001).ConclusionThe cognitive treatment can change erroneous cognitions related to sleeping in the insomniac and improve the therapeutic effect.